These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
520 related items for PubMed ID: 30281807
1. Prevalence characteristics of single and multiple HPV infections in women with cervical cancer and precancerous lesions in Beijing, China. Li M, Du X, Lu M, Zhang W, Sun Z, Li L, Ye M, Fan W, Jiang S, Liu A, Wang M, Meng Y, Li Y. J Med Virol; 2019 Mar; 91(3):473-481. PubMed ID: 30281807 [Abstract] [Full Text] [Related]
2. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China. Xiao M, Xu Q, Li H, Gao H, Bie Y, Zhang Z. Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906 [Abstract] [Full Text] [Related]
3. Distribution and diagnostic value of single and multiple high-risk HPV infections in detection of cervical intraepithelial neoplasia: A retrospective multicenter study in China. Ye Z, Zhao Y, Chen M, Lu Q, Wang J, Cui X, Wang H, Xue P, Jiang Y. J Med Virol; 2024 Aug; 96(8):e29835. PubMed ID: 39087721 [Abstract] [Full Text] [Related]
4. Genotype distribution of human papillomavirus (HPV) in histological sections of cervical intraepithelial neoplasia and invasive cervical carcinoma in Madrid, Spain. García-Espinosa B, Moro-Rodríguez E, Alvarez-Fernández E. BMC Cancer; 2012 Nov 20; 12():533. PubMed ID: 23167826 [Abstract] [Full Text] [Related]
5. Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology. Stoler MH, Wright TC, Parvu V, Yanson K, Cooper CK, Andrews J. Gynecol Oncol; 2019 Apr 20; 153(1):26-33. PubMed ID: 30638767 [Abstract] [Full Text] [Related]
6. Risks for cervical abnormalities in women with non-16/18 high-risk human papillomavirus infections in south Shanghai, China. Wang X, Wu S, Li Y. J Med Virol; 2021 Nov 20; 93(11):6355-6361. PubMed ID: 34232523 [Abstract] [Full Text] [Related]
9. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019. Liu Y, Ang Q, Wu H, Xu J, Chen D, Zhao H, Liu H, Guo X, Gu Y, Qiu H. Virol J; 2020 Jul 13; 17(1):104. PubMed ID: 32660490 [Abstract] [Full Text] [Related]
11. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population. Zhao XL, Hu SY, Zhang Q, Dong L, Feng RM, Han R, Zhao FH. J Gynecol Oncol; 2017 Jul 13; 28(4):e30. PubMed ID: 28541628 [Abstract] [Full Text] [Related]
13. Risk of high-grade precancerous lesions and invasive cancers in high-risk HPV-positive women with normal cervix or CIN 1 at baseline-A population-based cohort study. Mittal S, Basu P, Muwonge R, Banerjee D, Ghosh I, Sengupta MM, Das P, Dey P, Mandal R, Panda C, Biswas J, Sankaranarayanan R. Int J Cancer; 2017 Apr 15; 140(8):1850-1859. PubMed ID: 28108997 [Abstract] [Full Text] [Related]
17. Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study. Sun P, Song Y, Ruan G, Mao X, Kang Y, Dong B, Lin F. J Gynecol Oncol; 2017 Sep 15; 28(5):e50. PubMed ID: 28657218 [Abstract] [Full Text] [Related]